A multicenter phase II study of personalized FOLFIRI-cetuximab for safe dose intensification.
暂无分享，去创建一个
J. Raoul | J. Metges | E. Gamelin | M. Boisdron-Celle | A. Morel | O. Capitain | A. Adenis | R. Faroux | T. Lecomte | A. Poirier | C. Masliah | Y. Lam | V. Berger | Anne Lise Poirier